1. Home
  2. FSI vs BOLD Comparison

FSI vs BOLD Comparison

Compare FSI & BOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Flexible Solutions International Inc. (CDA)

FSI

Flexible Solutions International Inc. (CDA)

HOLD

Current Price

$5.03

Market Cap

63.7M

ML Signal

HOLD

Logo Boundless Bio Inc.

BOLD

Boundless Bio Inc.

HOLD

Current Price

$2.86

Market Cap

60.8M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
FSI
BOLD
Founded
1991
2018
Country
Canada
United States
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
63.7M
60.8M
IPO Year
2000
2024

Fundamental Metrics

Financial Performance
Metric
FSI
BOLD
Price
$5.03
$2.86
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$4.00
AVG Volume (30 Days)
21.0K
214.7K
Earning Date
04-15-2026
05-06-2026
Dividend Yield
1.53%
N/A
EPS Growth
N/A
32.47
EPS
N/A
N/A
Revenue
$15,494,325.00
N/A
Revenue This Year
$63.39
N/A
Revenue Next Year
$43.77
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.90
$0.96
52 Week High
$11.48
$2.92

Technical Indicators

Market Signals
Indicator
FSI
BOLD
Relative Strength Index (RSI) 29.81 78.79
Support Level $4.90 $2.39
Resistance Level $5.52 N/A
Average True Range (ATR) 0.17 0.11
MACD 0.00 0.01
Stochastic Oscillator 12.17 83.67

Price Performance

Historical Comparison
FSI
BOLD

About FSI Flexible Solutions International Inc. (CDA)

Flexible Solutions International Inc develops, manufactures, and markets specialty chemicals that slow the evaporation of water. Its business is organized into two segments: Energy and Water Conservation Products and Biodegradable Polymers. It offers a liquid swimming pool blanket under the WATERSAVR brand, which saves energy and water by inhibiting evaporation from the pool surface, and a chemical product called HEATSAV for use in swimming pools and spas to slow water evaporation. The company also manufactures and markets water-soluble chemicals utilizing thermal polyaspartate biopolymers. It generates the majority of its revenues from the export of its products to international markets.

About BOLD Boundless Bio Inc.

Boundless Bio Inc is a clinical-stage oncology company. It is focused on developing cancer therapeutics that address the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Using its proprietary Spyglass platform, the company identifies targets essential for ecDNA functionality, then designs and develops small-molecule drugs called ecDNA-directed therapies (ecDTx) to inhibit those targets. Its main ecDTx candidate under development, BBI-940, is a novel, oral, selective degrader that has demonstrated potent anti-tumor activity across a range of cancer cell lines and mouse xenograft models, including single-agent tumor regressions.

Share on Social Networks: